BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.97 USD | +1.12% |
|
-0.05% | -74.33% |
| Apr. 25 | Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing | MT |
| Apr. 23 | Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO | MT |
Chart calendar Biohaven Pharmaceutical Holding Company Ltd.
d27a4c73ae02c1.7cUxhcQQqLIis2G0crelWJPGwZHDOnQCMSVAqmcK9gQ.3fFY9JJj7PxM1QbyFN_zNsKwlc6nXzhxV24CyBZaulCJs2bLvHL3wGPUDg~f0113c64533ec1089c04901ebea7f0d5
Upcoming events on Biohaven Pharmaceutical Holding Company Ltd.
No events available
Past events on Biohaven Pharmaceutical Holding Company Ltd.
| 2022-09-28 | Extraordinary Shareholders Meeting |
| 2022-08-05 07:00 am | Interim 2022 Earnings Release |
| 2022-05-10 | Q1 2022 Earnings Call |
| 2022-05-10 06:50 am | Q1 2022 Earnings Release |
| 2022-04-28 09:00 am | Annual General Meeting |
| 2022-04-23 | American Academy of Neurology Meeting |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #998 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #2972 |
| 2022-04-01 | American Academy of Neurology Meeting - Oral No. #3807 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #873 |
| 2022-04-01 | American Academy of Neurology Meeting - Oral No. #1003 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #877 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #658 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #2972 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #3698 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #350 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #725 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #874 |
| 2022-04-01 | American Academy of Neurology Meeting - Abstract #1344 |
| 2022-02-25 08:30 am | FY 2021 Earnings Call |
Past dividends on Biohaven Pharmaceutical Holding Company Ltd.
| 2022-10-03 | 0 USD |
| 2022-10-03 | 148.5 USD |
Annual results
| Fiscal Period | December | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 63,6 63,5 0.16% | 463 451 2.65% |
|
EBITDA Million USD | Released Forecast Spread | -108 -121 10.86% | -224 -221 -1.42% | -478 -423 -12.99% | -636 -610 -4.18% | -679 -615 -10.46% |
|
EBIT Million USD | Released Forecast Spread | -108 -120 10.48% | -225 -226 0.65% | -479 -435 -10.04% | -645 -622 -3.72% | -704 -620 -13.6% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -126 -143 12.01% | -240 -238 -1.11% | -528 -482 -9.53% | -758 -725 -4.64% | -843 -786 -7.27% |
|
Net income Million USD | Released Forecast Spread | -139 -156 10.77% | -241 -238 -1.16% | -529 -483 -9.53% | -767 -725 -5.82% | -847 -782 -8.25% |
|
EPS USD | Released Forecast Spread | -5,00 -5,57 10.23% | -6,14 -6,06 -1.4% | -10,9 -9,95 -9.65% | -13,1 -12,4 -5.47% | -13,1 -12,1 -8.15% |
| Announcement Date | 06/03/18 | 28/02/19 | 25/02/20 | 01/03/21 | 25/02/22 |
Quarterly results
| Fiscal Period | December | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,70 7,43 30.49% | 17,7 19,3 -8.71% | 35,1 35,0 0.29% | 43,8 43,0 2% | 92,9 85,9 8.25% | 136 128 5.72% | 190 177 7.39% | 319 184 73.54% | 215 211 2.13% | |
|
EBITDA Million USD | Released Forecast Spread | -160 -122 -31.47% | -159 -161 0.66% | -166 -155 -7.03% | -231 -128 -79.66% | -166 -134 -23.33% | -134 -113 -19.04% | -149 -128 -16.35% | |||
|
EBIT Million USD | Released Forecast Spread | -161 -142 -13.46% | -163 -157 -3.89% | -171 -155 -9.8% | -236 -153 -54.44% | -172 -155 -10.86% | -140 -132 -5.9% | -157 -107 -46.03% | -53,8 -130 58.58% | -290 -146 -98.12% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -180 -144 -25.47% | -193 -172 -12.22% | -213 -175 -21.66% | -261 -171 -52.79% | -207 -180 -15.13% | -175 -159 -9.62% | -200 -134 -49.55% | -92,6 -150 38.19% | -442 -194 -127.74% | |
|
Net income Million USD | Released Forecast Spread | -181 -144 -25.83% | -195 -172 -13.65% | -218 -176 -24.01% | -261 -172 -52.02% | -211 -180 -17.12% | -172 -159 -7.73% | -199 -135 -47.68% | -209 -166 -26% | -441 -180 -144.55% | -68,9 |
|
EPS USD | Released Forecast Spread | -3,08 -2,44 -26.08% | -3,27 -2,93 -11.65% | -3,62 -2,96 -22.39% | -4,21 -2,90 -45.34% | -3,23 -2,79 -15.95% | -2,63 -2,39 -10.21% | -3,01 -1,95 -54.45% | -2,97 -2,60 -14.18% | -6,21 -2,51 -147.53% | -1,75 |
| Announcement Date | 10/08/20 | 09/11/20 | 01/03/21 | 10/05/21 | 09/08/21 | 09/11/21 | 25/02/22 | 10/05/22 | 05/08/22 | 09/11/22 |
More events
Past sector events for Biohaven Pharmaceutical Holding Company Ltd.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
- Stock Market
- Equities
- BHVN Stock
- Calendar Biohaven Pharmaceutical Holding Company Ltd.
